David P Schenkein Agios Pharmaceuticals, Inc. (AGIO) insider trading activity

David P Schenkein is Director of AGIOS PHARMACEUTICALS, INC.. Currently has a direct ownership of 126,242 shares of AGIO, which is worth approximately $7.01 Million. The most recent transaction as insider was on May 28, 2021, when has been sold 1,686 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 126K

0% 3M change

2.76% 12M change

Total Value Held $7.01 Million

David P Schenkein Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 28 2021	BUY Exercise of conversion of derivative security	-	1,686 Added 1.45%	114,277 Common Stock
Feb 22 2021	SELL Payment of exercise price or tax liability	-	821 Reduced 0.72%	112,591 Common Stock
Feb 22 2021	BUY Exercise of conversion of derivative security	-	2,774 Added 2.39%	113,412 Common Stock
Feb 16 2021	SELL Payment of exercise price or tax liability	-	2,540 Reduced 2.24%	110,638 Common Stock
Feb 16 2021	BUY Exercise of conversion of derivative security	-	8,125 Added 6.7%	113,178 Common Stock

Also insider at

REGN

REGENERON PHARMACEUTICALS, INC. Healthcare

Director

DNLI

Denali Therapeutics Inc. Healthcare

Director

PRME

Prime Medicine, Inc.

Director

DPS